Who Paid My Doc
Xenoview
Drug Respiratory
NDC 80534-6350-1
General payments
$505,375
Research payments
$157,343
Through program year 2025, $505,375 in general payments and $157,343 in research payments were reported against Xenoview (Respiratory).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $318,316 | 95 |
| 2025 | Research | $82,103 | 7 |
| 2024 | General | $131,403 | 40 |
| 2024 | Research | $75,240 | 2 |
| 2023 | General | $55,655 | 3 |
Breakdown
The top 5 of 41 recipients; each share is of general payments naming this product in 2025.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
138 general · 9 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.